Connect with us

Health

Drop-in COVID testing location changed to old Greyhound terminal

Published

on

CALGARY —
Alberta Health Services has switched the location of its drop-in COVID-19 testing centre in Calgary.

AHS confirmed Tuesday that it is now doing drop-in testing inside the former Greyhound Bus terminal, just off 14th Street between Ninth Avenue and Bow Trail S.W.

“Drop in COVID-19 testing in the Calgary Zone is now being provided at the Bow Trail assessment centre,” read a statement provided to CTV Calgary. “It is a larger space and better suited to accomodate people for both booked and drop-in testing.”

The Richmond Road Diagnostic and Treatment Centre, which had previously been the location for drop-in testing, still does tests but by appointment only.

Drop-in clients who come to the Richmond Road site are being told to go to the Bow Trail (Greyhound) site. They added that if people have no way to get to the Bow Trail site, they will do their best to provide one at Richmond Road.

AHS added that “the quickest and most efficient means of being tested continues to be booking an appointment online at www.ahs.ca/covid.” The online tool offers appointments for testing at all AHS asssessment centre locations that have testing availability within 75 kilometres of your postal code.

The AHS is also working with pharmacies, which it says are adding capacity for asymptomatic testing.

Source: – CTV Toronto

Source link

Continue Reading

Health

Task force worries Trump's rush to approve COVID-19 vaccine will cause concern in Canada – q107.com

Published

on


Members of the federal government’s COVID-19 vaccine task force are casting worried eyes at the Trump administration’s political push to get a vaccine approved before the U.S. presidential election in November.

Dr. Joanne Langley, the task force co-chair, and member Alan Bernstein say they are concerned about “vaccine hesitancy” in Canada, the phenomenon where people have doubts about taking a readily available vaccine because of concerns about its safety.

Read more:
How many Canadians have the new coronavirus? Total number of confirmed cases by region

Langley says that when a vaccine against COVID-19 is eventually found, governments and health-care professionals will have to mount a vigorous information campaign to counter opposition.

And it won’t help that U.S. President Donald Trump has said a pandemic-ending vaccine could be rolled out as soon as October, stoking concern that he is rushing the timeline to further his re-election chances on Nov. 3.

Countering concerns that an apparent hurry to approve a vaccine could spook people out of getting it is an ongoing concern among the approximately one dozen health experts on the government’s vaccine advisory panel.

It’s tasked with recommending which vaccine candidates the government should be spending money on.

This past week, Trump chided the director of the Centers for Disease Control and Prevention for being “confused” when he testified at a Senate committee that a safe and effective vaccine wouldn’t be ready by U.S. election day.

“As a scientist, and as a citizen, that’s concerning to me because the regulator is designed to be independent of any political influence,” Langley said in an interview. She is an expert in pediatric infectious disease at the Canadian Centre for Vaccinology at Dalhousie University.

“All the decisions are made based on the evidence of science, which includes the immune response, how well it protects, all of the adverse events,” she added. “And really, politicians have nothing to do with that.”

Read more:
Canada’s coronavirus cases are surging, but experts reject it’s a ‘second wave’

Bernstein said if politicians successfully pushed health regulators to approve a vaccine prematurely, that would violate public trust and discourage the widespread vaccine use needed to end the pandemic.

“I think it would be a big mistake. So I don’t see it happening before Nov. 3, no,” Bernstein said in an interview. Bernstein is the head of CIFAR, a Canadian-based global research organization.

“What a disaster it would be if we actually got a great vaccine, but in the U.S., the population didn’t trust it, because they felt that the decision was being compromised.”

In Canada, the federal government has made advance purchase deals with a handful of international biotech companies for tens of millions of vaccine doses if they are found to be safe and effective.

Canadian politicians and public health officials have said that widespread use of a vaccine is key to stamping out the novel coronavirus.

Bernstein said the government’s purchasing decisions have been based on recommendations born out of the painstaking research that his advisory group has undertaken. The task force reports to Health Minister Patty Hajdu and Innovation Minister Navdeep Bains.

“They’ve been very conscientious in terms of listening to us, visiting with us, talking with us. Both ministers,” said Bernstein, who was the first president of the Canadian Institutes of Health Research. He serves on medical advisory boards in the U.S., Britain and Australia, and with the Bill and Melinda Gates Foundation.

“Science is driving the decisions.”

Langley said there is an onus on governments and health professionals to communicate to Canadians the merits of taking a safe vaccine when a viable candidate is found and approved for use.

“We want to make sure that the Canadian public has a chance to learn about the very high standards that will have to be met for these vaccines,” she said, “and that they feel confident that people have chosen these vaccines with a view to their best interest.”

Read more:
Coronavirus took their lives. Here’s how their families will remember them

Bernstein said Canadians have a high level of trust in the institutions and political leaders.

“I’m not a Liberal or Conservative. I’m not commenting on Prime Minister Trudeau, but just in general, Canadians are pretty trusting, and that trust has been earned.”

Langley and her co-chair Mark Lievonen spent half a day briefing the Liberal cabinet during its two-day retreat in Ottawa this past week.

“It was all about the health consequences for Canadians of COVID and what we know so far, and what we might further be able to do and what the future is going to look like,” said Langley.

The vaccine task force was formally announced by the government in early August but it has been working since June. Over the summer it met in six-hour Zoom sessions at least twice a week, “interviewing various companies, various scientists, comparing notes with other national task forces to hear what they’re up to,” said Bernstein.

He and Langley are hopeful at least one viable vaccine candidate will emerge before the end of December from the several ongoing human trials.

Read more:
Trump contradicts health officials, claims coronavirus vaccine could be ready next month

They both say it could take several months after that before Health Canada gives the necessary final approval.

“We have to educate the public,” said Langley.

“It will be absolutely our responsibility to make sure that the public is informed so that they’re confident and can get those vaccines for themselves and their families knowing that the regular high standards that we have in Canada for vaccines are all met.”

© 2020 The Canadian Press

Let’s block ads! (Why?)



Source link

Continue Reading

Health

COVID-19 task force worries Trump’s rush to approve vaccine will spook Canadians

Published

on

Members of the federal government’s COVID-19 vaccine task force are casting worried eyes at the Trump administration’s political push to get a vaccine approved before the U.S. presidential election in November.

Dr. Joanne Langley, the task force co-chair, and member Alan Bernstein say they are concerned about “vaccine hesitancy” in Canada, the phenomenon where people have doubts about taking a readily available vaccine because of concerns about its safety.

Langley says that when a vaccine against COVID-19 is eventually found, governments and health-care professionals will have to mount a vigorous information campaign to counter opposition.

And it won’t help that President Donald Trump has said a pandemic-ending vaccine could be rolled out as soon as October, stoking concern that he is rushing the timeline to further his re-election chances on Nov. 3.

Countering concerns that an apparent hurry to approve a vaccine could spook people out of getting it is an ongoing concern among the approximately one dozen health experts on the government’s vaccine advisory panel.

It’s tasked with recommending which vaccine candidates the government should be spending money on.

This past week, Trump chided the director of the Centers for Disease Control and Prevention for being “confused” when he testified at a Senate committee that a safe and effective vaccine wouldn’t be ready by U.S. election day.

“As a scientist, and as a citizen, that’s concerning to me because the regulator is designed to be independent of any political influence,” Langley said in an interview. She is an expert in pediatric infectious disease at the Canadian Centre for Vaccinology at Dalhousie University.

“All the decisions are made based on the evidence of science, which includes the immune response, how well it protects, all of the adverse events,” she added. “And really, politicians have nothing to do with that.”

Bernstein said if politicians successfully pushed health regulators to approve a vaccine prematurely, that would violate public trust and discourage the widespread vaccine use needed to end the pandemic.

“I think it would be a big mistake. So I don’t see it happening before Nov. 3, no,” Bernstein said in an interview. Bernstein is the head of CIFAR, a Canadian-based global research organization.

“What a disaster it would be if we actually got a great vaccine, but in the U.S., the population didn’t trust it, because they felt that the decision was being compromised.”

In Canada, the federal government has made advance purchase deals with a handful of international biotech companies for tens of millions of vaccine doses if they are found to be safe and effective.

Canadian politicians and public health officials have said that widespread use of a vaccine is key to stamping out the novel coronavirus.

Bernstein said the government’s purchasing decisions have been based on recommendations born out of the painstaking research that his advisory group has undertaken. The task force reports to Health Minister Patty Hajdu and Innovation Minister Navdeep Bains.

“They’ve been very conscientious in terms of listening to us, visiting with us, talking with us. Both ministers,” said Bernstein, who was the first president of the Canadian Institutes of Health Research. He serves on medical advisory boards in the U.S., Britain and Australia, and with the Bill and Melinda Gates Foundation.

“Science is driving the decisions.”

Langley said there is an onus on governments and health professionals to communicate to Canadians the merits of taking a safe vaccine when a viable candidate is found and approved for use.

“We want to make sure that the Canadian public has a chance to learn about the very high standards that will have to be met for these vaccines,” she said, “and that they feel confident that people have chosen these vaccines with a view to their best interest.”

Bernstein said Canadians have a high level of trust in the institutions and political leaders.

“I’m not a Liberal or Conservative. I’m not commenting on Prime Minister Trudeau, but just in general, Canadians are pretty trusting, and that trust has been earned.”

Langley and her co-chair Mark Lievonen spent half a day briefing the Liberal cabinet during its two-day retreat in Ottawa this past week.

“It was all about the health consequences for Canadians of COVID and what we know so far, and what we might further be able to do and what the future is going to look like,” said Langley.

The vaccine task force was formally announced by the government in early August but it has been working since June. Over the summer it met in six-hour Zoom sessions at least twice a week, “interviewing various companies, various scientists, comparing notes with other national task forces to hear what they’re up to,” said Bernstein.

He and Langley are hopeful at least one viable vaccine candidate will emerge before the end of December from the several ongoing human trials.

They both say it could take several months after that before Health Canada gives the necessary final approval.

“We have to educate the public,” said Langley.

“It will be absolutely our responsibility to make sure that the public is informed so that they’re confident and can get those vaccines for themselves and their families knowing that the regular high standards that we have in Canada for vaccines are all met.”

Source:- PrinceGeorgeMatters.com

Source link

Continue Reading

Health

COVID-19 case identified at Winnipeg daycare – CBC.ca

Published

on


Public health officials are warning that a confirmed case of COVID-19 is connected to the Munroe Early Childhood Education Centre in Winnipeg’s Elmwood neighbourhood.

A person who tested positive for the novel coronavirus was in the Chalmers Avenue daycare on Monday in the morning and afternoon, according to a letter sent to parents from the Winnipeg Regional Health Authority on Saturday.

“Be assured that public health investigations begin within 24 hours of a confirmed laboratory test to identify individuals who may have been exposed,” the letter said.

The centre immediately closed off areas that may have been used by the infected person after it was informed of the positive test result. Those areas won’t be used until they have been thoroughly cleaned.

All close contacts in the same room as the person who tested positive are being told to self-isolate for 14 days, but public health officials will contact those people directly.

Officials aren’t providing the name or any identifying information about the person who tested positive.

Parents are asked to monitor their kids for COVID-19 symptoms and isolate them at any sign of illness; those who show symptoms should be tested for the coronavirus.

The centre will remain open to all other children and staff.

Let’s block ads! (Why?)



Source link

Continue Reading

Trending